The ascendancy of Viagra and its impact on the drug landscape presents a intricate question for investors. While the initial sales figures were astounding, the patent has expired, leading to a deluge of copycat alternatives that are reducing profit. In addition, the sector is facing difficulties related to aging trends and shifting healthcare guide